SGB confident of booster shot efficacy

Solution Biologics bottling CanSino vaccine at Bukit Jalil. - Filepic

KUALA LUMPUR: Solution Group Bhd (SGB) is confident that the China-based single-dose Convidecia vaccine will be an effective booster shot against the spread of Covid-19 variants.

SGB’s wholly-owned subsidiary, Solution Biologics Sdn Bhd (Solbio), is the Asean manufacturing partner for CanSino’s Convidecia vaccine.

In a statement yesterday, SGB said data from a recent Chinese clinical study showed that a booster shot with the Convidecia vaccine, following a two-dose inactivated vaccine, is effective to produce an immune response to the Covid-19 virus.

“The study by the Jiangsu Centre of Disease Control revealed that the Convidecia booster shot demonstrated an increase of at least 78-fold in average neutralising antibody levels, in comparison with a booster shot with the same inactivated vaccine showing a 15.2-fold increase in antibody levels,” it said.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 0
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In Business News

Wall St set for subdued open ahead of Fed rate decision, Powell comments
Pavilion REIT unitholders approve Bukit Jalil Mall acquisition
Hap Seng to dispose of entire stake in HS Credit (Manchester) for RM837.34mil
PTP to invest RM3bil in next five years for additional 3.5 mil TEUs capacity
Ringgit continues rise against US dollar for third consecutive day
EcoWorld International on track to hit RM1.4bil sales target
VS Industry’s 2Q net profit falls to RM30.36mil
Uzma wins RM68.1mil contracts from Sabah Shell
Bank Negara international reserves fall to US$114bil as at March 15
SEMI: Global fab equipment spending to rise to US$92bil in 2024